Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)

Completed · Phase 2

Conditions studied: Pseudohypoparathyroidism Type 1a, Albright Hereditary Osteodystrophy

In brief

This study will test an investigational drug, theophylline, in children with pseudohypoparathyroidism type 1a (PHP1a). This study involves a 3 day visit to the Vanderbilt Clinical Research Center.

Key facts

Study ID
NCT02463409
Run by
Vanderbilt University Medical Center
People needed
6
Starts
2015-06-01
Expected to finish
2016-10-01
Last updated by the study team
2017-06-26

Who can join

Age: 10 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.